Moleac is a Singapore-based biopharmaceutical company founded in 2003 that dedicates itself in finding and developing new medicines for the unmet needs of patients worldwide. 
Moleac's medicines reach millions of patients worldwide, suffering from Neurological, Cardio-Vascular and Aging conditions.





LevPharm Ltd has signed an agreement with OssDsign to represent it in Israel and markets its products in the NeuroSurgery field  

 Lev Pharm ltd.  10 Levinson str. Petah-Tikva 49401 Israel     Tel: +972-3-9230851   Fax:  +972-3-9245074